AU729778B2 - Antisense nucleotide sequences - Google Patents

Description

ANTISENSE NUCLEOTIDE SEQUENCES BACKGROUND OF THE INVENTION This invention relates to a technique for suppressing protein synthesis using antisense nucleotide sequences, particularly to a technique capable of enhanced suppression of protein synthesis.

PRIOR ART It is known that functional RNAs such as messenger RNA which provides information on protein synthesis are suppressed by RNAs having complementary nucleotide sequences to the aforementioned RNA, which are collectively referred to as antisense RNAs. Research is under way to create plants wherein antisense RNA is introduced artificially by gene recombinant technology. Genes for expressing antisense RNAs are constructed in such a manner that a sequence corresponding to a partial or full length of a DNA sequence (cDNA or genomic DNA) coding for a protein of interest is connected downstream of a promoter in the antisense direction.

While various antisense techniques have been proposed, the following are worth mentioning: Recombinant petunia was prepared that produced an.

antisense RNA against RNA of a chalcone synthase gene participating in the synthesis of flower pigments, and the recombinant petunia presented a different flower color than the wild type (EP 34-1885A); The expression of a polygalacturonase gene, a key 7N factor in tomato fruit losing its firmness, was suppressed 1 by an introduced antisense RNA to create tomatoes that could be preserved for a longer period than the wild type (EP 891115A); Melton et al. used a full-length sequence of 3-globin cDNA as an antisense gene (Proc. Natl. Acad. Sci. USA 82:144-148 (1985)); Stockhaus et al. used as an antisense gene a sequence corresponding to the full length of a 10 kD protein cDNA which takes part in the photo-system of photosynthesis (the EMBO Journal 9:3013-3021 (1990)); Alexander et al. used as an antisense gene a sequence corresponding to the full length of chalcone synthase cDNA which takes part in the synthesis of flower pigments (Nature 333:866-869(1988)); Hamilton et al. used a sequence corresponding to the full length of ethylene synthase (ACC-oxidase) cDNA as an antisense gene (Nature 346:284-287 (1990)); and Smith et al. used a sequence corresponding to a partial length of polygalacturonase cDNA as an antisense gene (Nature 334:724-726 (1988)).

Thus, in the conventional antisense-related technology, a nucleotide sequence corresponding to a partial or full length of the nucleotide sequence coding for a protein of interest is simply inserted as an antisense gene in the reverse direction at a downstream of a promoter.

While several reports have been published which propose methods for reducing the content of a protein of Sinterest using antisense RNA, there is no report of success 2 in reducing protein synthesis when the protein is one of those occurring abundantly in vivo as exemplified by the storage proteins in plant seeds. In order to ensure that the content of a protein occurring abundantly in vivo is reduced using an antisense RNA, the latter must be provided in a large amount at the site of its syntheses. One possible means of satisfying this need is to introduce the antisense gene in multiple copies; however, if homozygote is desired as in the case where the host is a plant, the problem is that a great amount of work is required to fix a gene introduced in multiple copies by self-fertilization.

Another possible means is to enhance the activity of a promoter that expresses an antisense gene of interest, but this also is not easy to accomplish.

The antisense genes reported thus far do not provide an easy way to reduce the content of proteins that occur abundantly in vivo.

SUMMARY OF THE INVENTION It is generally believed that the degree of suppression of protein synthesis increases with the increasing expression of associated antisense genes (Melton D.A. et al. (1985) Proc. Natl. Acad. Sci. USA 82, 144-148; and Ecker J.R. et al. (1986) Proc. Natl. Acad. Sci. USA 83, 5372-5376). As already mentioned, the expression of an antisense gene could be increased by, for example, enhancing the activity of a promoter used in expressing the antisense gene or by introducing it in an increased copy number.

I, However, both methods are subject to the problems described 3 above. The purpose of the present invention is to provide an antisense gene that can not only suppress the synthesis of a protein in vivo more efficiently but also lower even the content of a protein that occurs abundantly in vivo.

If a nucleotide sequence corresponding to a full length of a structural gene of interest is introduced in the antisense direction, the effectiveness in reducing the synthesis of a protein of interest is indeed increased to some extent. However, according to this method in which a nucleotide sequence corresponding to the full length of the structural gene of interest is introduced in the antisense direction, it is possible that an unknown open reading frame will appear, thereby inducing the expression of an unexpected protein in the host. Particularly in the case of edible plants, safety to humans and changes in taste are two important factors that must be considered seriously. The problem of the expression of an unexpected protein can be solved by suppressing it using a sequence corresponding to a portion of the structural gene, namely, a partial sequence which lacks an open reading frame or one from which an open reading frame has been deleted artificially. However, if a part of the structural gene of interest is introduced as a single unit, the effectiveness in reducing the synthesis of the protein by the structural gene will not be attained at the intended level. Under the circumstances, the present inventors conducted intensive studies in order to develop a method for solving the aforementioned problems by reducing "he synthesis of a protein of interest without expressing 4 any unknown protein. As a result, the inventors found a method wherein an antisense nucleotide sequence is prepared so that it comprises a plurality of the structural gene of interest or a fragment thereof linked in succession, and said sequence is introduced into a genomic gene in a target cell; the present invention has been accomplished on the basis of this finding.

BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 shows schematically the structures of genes used in the in vitro RNA syntehsis; Fig. 2 shows electrophoretic patterns in the analysis of translation products in a wheat germ extract; Fig. 3 is a graph showing the changes in the amount of glutelin synthesis; Fig. 4 shows schematically the structure of a plasmid vector used in transformation; Fig. 5 shows an electrophoretic pattern in the PCR analysis of transformants having a sequence comprising 8 repeats of glutelin A antisense gene introduced therein; Fig. 6 shows an electrophoretic pattern in the PCR analysis of transformants having a full length of glutelin A antisense gene introduced therein; Fig. 7 shows an electrophoretic pattern in the northern analysis of transformants having a sequence comprising 8 repeats of glutelin A antisense gene introduced therein; and Fig. 8 shows schematically the structure of the \plasmid vector used in the transformation.

5 DETAILED DESCRIPTION OF THE INVENTION The present inventors have found that an antisense nucleotide sequence may be formed such that it comprises two or more units of a structural gene of interest or a sequence representing a part of said structural gene in succession in the antisense direction, and said sequence is introduced into a genomic gene in a target cell so as to suppress the intracellular expression of a protein encoded by the structural gene effectively. The present invention was accomplished on the basis of this finding.

Thus, according to one aspect of the invention, there is provided an antisense nucleotide sequence in which two or more units of a structural gene of interest or a sequence representing a part of said structural gene are linked in succession in the antisense direction. An antisense RNA transcribed from the antisense nucleotide sequence of the invention comprises in the molecule two or more successive repeats of an RNA sequence complementary to the part of mRNA coding for a protein of interest. Therefore, the transcribed antisense RNA will form a pair with the strand of the mRNA coding for the protein of interest, thereby enhancing the possibility of suppressing the expression of said protein in vivo. Accordingly, the antisense RNA comprising the repeats of a complementary RNA sequence is more effective in suppressing the synthesis of the protein of interest than antisense RNA having no such repeats of a sequence unit.

4"According to further aspects of the invention, there 6 are provided an expression vector having the antisense nucleotide sequence of the invention, a transformant obtained by transformation with said expression vector, and a method of suppressing the intracellular expression of a protein encoded by a structural gene which includes the step of introducing the antisense nucleotide sequence of the invention into a genomic gene in a target cell.

The invention will now be described in detail.

According to a first aspect of the invention, there is provided an antisense nucleotide sequence in which two or more repeats of a structural gene of interest or a sequence representing a part of said structural gene are linked in succession in the antisense direction.

The term "a structural gene of interest" as used herein means a gene coding for a protein whose expression is desired to be suppressed. The protein to be under expressed is not limited to any particular type as long as it is produced in vivo; however, proteins that are expressed abundantly in vivo are preferred targets since the antisense nucleotide sequence of the invention will work more effectively. Examples of such proteins are storage proteins in plant seeds. More specific examples include glutelin, prolamin, globulin, albumin and so forth in cereals; particularly, rice glutelin, wheat glutenin, maize zein and barley hordein occur abundantly in seeds. Other examples include soybean conglycinin, kindney bean phaseolin, as well as potato patatin and sweet potato sporamin.

SIn the Examples that are given hereinafter, glutelins 7 A and B, storage proteins in rice, were used but they are just intended as illustrative embodiments of the invention.

In the invention, the entire sequence of a particular structural gene may be employed or, alternatively, a sequence representing a part of said gene may be employed.

In the latter case, a sequence from around the 5' side is preferably used because a complementary sequence corresponding to the initiation site of the structural gene is more effective in suppressing the expression of the protein of interest.

If a partial sequence is used, its size is not limited to any particular length; generally, a sequence length of at least 45 nucleotides is preferred, with a length of at least 300 nucleotides being particularly preferred (Tada et al. (1996) Breeding Science 46, 403-407).

The antisense nucleotide sequence of the invention is such that multiple units of the above-described sequence are linked in succession in the antisense direction.

The term "antisense direction" as used herein means such a direction that at least a part of the antisense DNA sequence is oriented to provide a region which is complementary to the genomic DNA of host cells. The transcript from the complementary gene has a sequence that is complementary to the RNA sequence, particularly mRNA, which is endogenous in the host.

The term "multiple units" as used herein means at least two units, preferably at least 4 units, more preferably at least 8 units.

8 The term "in succession" as used herein means that adjacent units of the sequence are not interrupted by any other nucleotide or that any intervening sequence is not a promoter or other sequences that will cause significant effects on the expression of the structural gene.

In the invention, multiple units of the antisense nucleotide sequence can be linked by any customary methods used in genetic engineering technology and appropriate methods may be applied without any particular limitations.

In an exemplary method, a structural gene of interest is cloned in a plasmid and the sequence containing a full length of the structural gene or a fragment thereof, containing a part of the structural gene (such sequence or a fragment thereof is referred to as an insert) is excised from a plasmid. Different restriction sites are introduced at the two terminal ends of the excised insert by a suitable means such as the addition of linkers. In this case, it is important that the sequence at the cloning site of the vector plasmid vector) in the subsequent cloning step is taken into consideration, in order to ensure that the restriction sites at the two terminal ends of the insert may be designed in such a way that the resulting plasmid contains the structural gene of interest in the antisense direction. Subsequently, the vector having the different restriction sites at the two ends and the insert having the corresponding restriction sites at the two terminal ends are ligated to produce a gene construct containing one antisense nucleotide sequence.

9 In the next step, a construct is linearized by treatment with a restriction enzyme and different restriction sites are introduced at the two terminal ends.

In the same manner as described in the preceding paragraph, another insert containing a full or partial length of the structural gene is excised and the corresponding restriction sites are introduced at the two terminal ends of the insert.

The resulting sequence is ligated with the linearizied construct to thereby produce a gene construct containing two antisense sequences.

The same procedure may be repeated as many times as is required to produce a gene construct containing a desired number of antisense nucleotide sequences. It is also possible to start from a gene construct containing two antisense nucleotide sequences, and excise a fragment containing the antisense sequences to be used as an insert thereby to obtain a gene construct containing four antisense sequences through one ligation step. Similarly, starting from a gene construct containing four antisense sequences, a gene construct containing eight antisense sequences can be prepared through one ligation step.

In one embodiment, the invention also provides an antisense nucleotide sequence which comprises two or more different types of structural genes or sequences representing a part of them, as the structural genes of interest. Stated specifically, if different types of structural genes are to be underexpressed simultaneously, a transforming gene construct may be so designed that it 10 comprises a linkage of multiple units of transforming gene constructs each comprising an antisense nucleotide sequence of the invention that is placed downstream of a promoter and followed by a terminator. Since each of said gene construct units comprises an antisense sequence of a different type of structural gene or a part thereof oriented in the antisense direction, multiple structural genes can be suppressed from expression by use of a single transforming gene construct.

According to a second aspect of the invention, there is provided an expression vector having the antisense nucleotide sequence of the inveniton.

In constructing the expression vector, regulator such as a promoter and a terminator, and a transformation vector may be appropriately selected from among those which are customarily used in genetic engineering and they are not limited to any particular types.

Exemplary promoters include glutelin promoter, conglycinin promoter, phaseolin promoter, ADH promoter, heat shock protein promoter, a tissue specific promoter, a promoter associated with fruit ripening, prolamin promoter, RUBP carboxylase small subunit promoter cauliflower mosaic virus promoter, and so forth.

Exemplary terminators include nopalin synthase terminator, cauliflower mosaic virus terminator, and so forth.

Exemplary vectors include pUC plasmid vector, pBR Splasmid vector, Ti plasmid vector, Ri plasmid vector, and so forth.

11 According to a third aspect of the invention, there is provided a transformant produced by transformation with the expression vector of the invention.

The organisms to be transformed are not limited to any particular types and may be selected as appropriate from among plants, animals, microorganisms and so forth. In the present invention, transformants are preferably plants, in particular, higher plants such as monocotyledons and dicotyledons; particularly preferred are cereals rice, wheat, maize and barley), soybean, kidney bean and potato and sweet potato.

According to a fourth aspect of the invention, there is provided a method in which intracellular expression of proteins encoded by structural genes is suppressed by introducing the antisense nucleotide sequence of the invention into a genomic gene in a target cell.

The method of introducing the antisense nucleotide sequence of the invention into a genomic gene in a target cell is not limited in any particular way and a suitable transforming technique may be employed depending upon a specific object.

For example, the antisense nucleotide sequence of the invention may be introduced into genomic genes in plant cells by the use of Agrobacterium tumefaciens, electroporation into protoplasts, liposome fusion, microinjection, and so forth.

Plant cells into which the antisense nucleotide R sequence has been sucessfully introruced can be selected by 12 a suitable technique such as screening of antibiotic resistant cells. The thus transformed plant cells may be cultured for regeneration into intact plants. The regenerated plant can be fixed in a variety by customary breeding techniques.

The antisense nucleotide sequence may be introduced into genomic genes in animal cells by electroporation, liposome fusion, microinjection and other suitable methods.

The antisense nucleotide sequence may be introduced into genomic genes in microorganism cells by the calcium method, electroporation and other suitable methods.

The following examples are provided for the purpose of further illustrating the present invention but are in no way to be taken as limiting.

EXAMPLES

In the examples, an attempt was made to suppress the storage proteins of rice, glutelin, by way of antisense RNAs in order to reduce the glutelin content in rice endosperm.

With regard to glutelin, rice contains 10 or more genes in the genome coding for either glutelin A or glutelin B. The homology of their nucleotide sequences is 65%. Reducing the glutelin content of rice provides the rice with better quality for brewery.

A brief summary of the steps employed in the examples is as follows. Where no specific indication is made, the methods are in accordance with Maniatis T. et al. (Molecular Cloning, Cold Spring Harbor (1982)).

S(a) The full length cDNAs of the rice storage proteins, 13 glutelin A and glutelin B were isolated (Okita et al. (1989) Journal. Biochemical Chemistry 264: 12573-12581). The entire nucleotide sequences of the cDNAs of glutelin A and glutelin B are shown as SEQ ID NO: 1 and SEQ ID NO: 2, respectively.

A plurality of the 312 bps sequence from the upstream of the full length cDNA of glutelin A were linked in the antisense direction.

The antisense gene comprising the linkage was used as the template for in vitro transcription to prepare the corresponding antisense RNA.

The antisense RNA was mixed with the sense RNA of glutelin A and the mixed solution was used in in vitro translation to study the amount of glutelin A synthesis.

The first intron of castor bean catalase gene (Ohta S. et al. (1990) Plant Cell Physiol. 31, 805-813) was introduced downstream to the glutelin promoter; and 8 repetitions of the 312 bps sequence from the 5' upstream of the full length cDNA of glutelin A were placed downstream to said intron. A terminator of nopaline synthase was further added to provide an expression plasmid vector. Similarly, an antisense gene comprising 8 repetitions of the 287 bps sequence from the 5' upstream of the full length cDNA of glutelin B was prepared, which was then introduced into said expression plasmid vector.

The expression plasmid vector was used to transform a rice plant and the glutelin content in the rice seeds was h studied.

14 Example 1. In vitro effects of tandem-repeated antisansc

RNA

RNA synthesis in vitro Synthesis of sense mRNA for glutelin A A full-length glutelin A cDNA was inserted, in the sense direction, into the multiple cloning site EcoRI/BamHl that is located downstream of the T7 promoter in Bluescript plasmid(product from Toyobo Co.) (Fig. 1, Glu sense RNA).

Transcription was carried out in a reaction mixture containing the plasmid described above (5 ig of DNA in il) by adding thereto 20 mM each of ATP, CTP, and GTP (4 2.5 mM GTP (1 pl), 5 mM Cap analogue (5 0.5 M DTT (1 Rl), RNase inhibitor (50 units), and T7 RNA polymerase units). The reaction mixture was incubated for 30 min at 37 0 C and further 4.5 hr at 37 0 C after addition of 20 mM GTP (1 il).

Synthesis of glutelin A antisense RNA A full-length glutelin A cDNA was inserted, in the antisense direction, to the multiple cloning site BamHI/EcoRI that is located downstream of the T7 promoter in Bluescript plasmid(product from Toyobo Co.) (anti-full RNA).

Similarly, a 312 bps fragment from the 5'-end of glutelin A cDNA sequence was inserted in Bluescript plasmid in the antisense direction, singly (anti x 1 RNA), 4-times repeatedly (anti x 4 RNA), or 8-times repeatedly (anti x 8 RNA) (Fig. 1) as follows. First, a XbaI linker (CTCTAGAG) was added to the StuI site that existed at 312 bps R-\Idownstream from the 5'-end of glutelin A cDNA. Plasmid anti 15 x 1 RNA was constructed by inserting the BamHI/XbaI fragment thereof into the multiple cloning site Xbal/BamHI, which is located downstream of the T7 promoter, in Bluescript plasmid (product of Toyobo Next, a BamHI linker (CGGATCCG) was added to the StuI site which is located 312 bps downstream from the 5'-end of glutelin A cDNA, and the BamHI/ScaI fragment separated therefrom was inserted into the BamHI/SmaI site of the above plasmid anti x 1 RNA, to provide plasmid anti x 2 RNA. The plasmid was digested at the XbaI site, treated with DNA polymerase to fill in the sticky ends, and subsequently treated with EcoRI to provide a fragment containing two of said 5'end sequence of appoximately 312 bps. Separately, plasmid anti x 2 RNA was digested at the PstI site, filled in by DNA polymerase, and cleaved with EcoRI. Plasmid anti x 4 RNA was constructed by inserting the above fragment into this EcoRI site.

Similarly, plasmid anti x 8 RNA was constructed by inserting the XhoI fragment which was removed from plasmid anti x 4 RNA after the Xbal cut site was filled in by treatment with DNA polymerase into the HincII/XhoI site of plasmid anti x 4

RNA.

Transcription was carried out in a reaction mixture that contained the plasmid (5 Vg of DNA), a mixture of 20 mM each of ATP, CTP, UTP, and GTP (5 0.5 M DTT (1 l), RNase inhibitor (50 units), and T7 RNA polymerase units), by incubation at 37 0 C for 5 hr,.

In vitro translation reaction by using wheat germ Sextract 16 Translation experiments were conducted by using wheat germ extract (Amersham). To the Glu sense RNA (2 picomoles) that had translation activity to glutelin was added antisense RNA against glutelin sense RNA as follows: antifull RNA, anti x 1 RNA, anti x 4 RNA, or anti x 8 RNA, to provide an amount of 0.2, 0.5, 1, and 2 picomoles, respectively. Translation reaction was carried out at 30 0

C

for 1 hr after addition of 15 p1l of wheat germ extract to a mixture containing 2 p1l of 1 mM amino acid mixture (19 amino acids lacking methionine) and 0.5 p1l of S-methionine (1,000 Ci/mmol). The reaction was terminated by addition of SDS (2.5 followed by heating at 95 0 C for 5 min. The translation products were separated by electrophoresis on 13% polyacrylamide gel. The radioactivity was detected and measured by using Imaging analyzer (Fuji Film Co.).

In vitro analysis of the effect of antisense RNA Amount of the translation product synthesized by wheat germ extract, in the presence of the antisense RNAs, was analyzed by using Imaging analyzer (Fig. No band appeared if no RNA was added (lane while the glutelin band appeared when the glutelin sense RNA alone was added (lane However, the intensity of the glutelin band was smaller as the moles of the antisense RNA added was greater (lanes 3-6) From the radioactivity of the glutelin bands, amounts of glutelin synthesized under the given conditions were determined. The graph (Fig. 3) shows the results for the N amounts of glutelin synthesized under the given conditions, 17 in percentage as compared with the control which contained no antisense RNA. The decrease of glutelin depended on the number of the linked 5'-upstream 312 bps sequences of the glutelin A cDNA. Such decrease was larger in cases in which the antisense RNA comprised 4-tandem repeats or 8-tandem repeats of the 5'-upstream 312 bps sequence than in the case in which the full-length glutelin antisense RNA was used.

Example 2. Production and analysis of transgenic plants transformed by glutelin A antisense gene Construction of 8-tandem repeats of glutelin A antisense gene for transformation A SmaI/XbaI fragment containing the first intron of the castor bean catalase gene (Ohta S. et al. (1990) Plant Cell Physiol. 31, 805-813) was inserted into the Scal/XbaI site downstream of the glutelin promoter (Takaiwa et al.

(1987) FEBS Lett. 221:43-47), and then a XbaI/SacI fragment containing 8-tandem repeats of the 5'-upstream 312 bps from the glutelin A cDNA was inserted into its downstream, in the antisense direction. A SacI/EcoRI fragment containing the terminator of nopalin synthase (Depicker et al. (1982) J.

Mol. Appl. Genet. 561-573) was joined to it and then the so formed antisense gene was inserted into a plasmid vector having a hygromycin resistance gene, to generate pSBHCI x 8A (Fig. The intron inserted in the plasmid enhances the expression of glutelin A antisense gene.

Construction of a full-length glutelin A antisense gene _for transformation A SmaI/XbaI fragment containing the first intron of 18 the castor bean catalase gene (Ohta S. et al. (1990) Plant Cell Physiol. 31, 805-813) was inserted into the ScaI/XbaI site downstream of the glutelin promoter, and then the Sacl/XbaI fragment containing glutelin A cDNA was inserted into its downstream, in the antisense direction. A Sacl/EcoRI fragment containing the terminator of nopalin synthase was joined to it and then the so formed antisense gene was inserted into a plasmid vector having a hygromycin resistance gene, to generate pSBHCI-FA (Fig. 4).

Transformation to rice plants A variety of the rice plant, "Tsukinohikari", was transformed by Agrobacterium tumefaciens LBA4404 which harbored the above plasmid pSBHCI x 8A or pSBHCI-FA, according to the method of Hiel et al. (Plant J. 6, 271-282 (1994)). Transformed calluses were selected in the presence of hygromycin as described by Hiel et al. (ibid).

Preparation of DNA and RNA DNA of transgenic plants was prepared from redifferentiated seedlings before they were transferred to pot cultivation in a closed greenhouse.

RNA was prepared by the SDS-phenol method (Uchimiya et al. Manual for plant genetic engineering, Kodansha Co., Tokyo, Japan).

PCR and Northern analyses of transformed plants Transformation was confirmed by detecting the glutelin antisense gene after the gene was amplified by PCR.

Genomic DNA (120 ng), four dNTPs (200 VM each), primers Spmol/reaction), and Taq DNA polymerase (Takara Biomedicals 19 Co.) (1 unit) were mixed. The mixture was heated for 2 min at 94 0 C, 50 0 C, and 72 0 C, respectively, in the first cycle, and subsequently 1 min at each temperature for 34 cycles.

For amplification of the 8-tandem repeats of the glutelin antisense gene, the following primers were used: 5'-AGTGGGCTGCAGGAATTCGATATCAAGCTT-3' (SEQ ID NO:3) 5'-AGTACATAGCAGCAAAACAT-3' (SEQ ID NO:4) Similarly, for amplification of the full-length glutelin A antisense gene, the following primers were used: 5'-TACATAGCTTTAACTGATAATCTGA-3' (SEQ ID 5'-AGTACATAGCAGCAAAACAT-3' (SEQ ID NO:6) Northern analysis was performed according to a conventional procedure after total RNA (20 pg) was separated by electrophoresis on 1% agarose gel. The total RNA was prepared, for this analysis, from immature seeds 8 days after flowering of the transformant which was confiremed to have the 8 tandem-repeats of the glutelin A antisense gene, or those of the control plant that was transformed with the hygromycin resistance gene alone. The probe was the upstream 312 bps sequence derived from glutelin A cDNA.

The probe, (25 ng of a DNA fragment) was labeled with 32 P by using Ready Prime DNA Labeling System (Amersham), before the Northern analysis.

Production of transformants with 8 tandem-repeats of the glutelin A antisense gene Individual 20 redifferentiated lines were obtained by regeneration of hygromycin-resistant calluses that had been transformed with the 8-tandem repeats of glutelin A 20 antisense gene. Transformation by the antisense gene was confirmed by PCR followed by agarose electrophoresis as shown in Fig. 5. A band appeared, as expected, at the position of approximately 1.2 kbps, in the lane where the plasmid containing the antisense gene was used as a template in the PCR (Fig. 5, lane All 20 transformed lines gave the same band at 1.2 kbps (Fig. 5, lanes 3-22). No such band was detected when the DNA, from untransformed lines, was used for a template in the PCR reaction (Fig. 5, lane 23).

Accordingly, we concluded that the above transformants carried the 8-tandem repeats of the glutelin antisense gene.

Production of transformants with full-length glutelin antisense gene Individual 18 redifferentiated plant lines were obtained by regeneration from hygromycin-resistant calluses that had been transformed with the full-length glutelin A antisense gene. Fig. 6 shows the results of agarose electrophoresis after PCR to confirm the introduction of the antisense gene. A band appeared, as expected at the position of approximately 1.7 kbps, in the lane where the plasmid containing the antisense gene was used as a template (Fig. 6, lane All 18 transformants gave the same band at 1.7 kbps (Fig. 6, lanes 3-20). No such band was detected when the DNA, from untransformed lines, was used for a template in the PCR reaction (Fig. 6, lane 21).

Accordingly, we concluded that the above 18 21 transformants carried the full-length glutelin A antisense gene.

Analysis of transcription product in immature seeds from transformed plants Fig. 7 shows the results of Northern analysis for control five lines and ten transformed lines. The transformed lines carrying the 8-tandem repeats of the glutelin A antisense gene produced apparently less amount of glutelin A mRNA (Fig. 7, lanes 6-15) than the control five lines (Fig. 7, lanes Table 1 shows the intensity of signals as determined by Bio-imaging analyzer BAS1000 (Fuji Film The results are expressed in percentage of the mean value from the five control lines. Thus, we confirmed that the content of glutelin A mRNA was significantly lower in immature seeds of the transformants, by the effect of the introduced 8-tandem repeats of the glutelin antisense gene.

Table 1. Level of transcription product in immature seeds Lane number Control 6 7 8 9 10 11 12 13 14 100 31.1 11.9 13.1 11.7 10.0 7.7 8.2 3.8 3.0 1.2 Measurement of protein content in the seeds Unpolished seeds from self-fertilized rice plants were ground and the proteins were extracted from 50 mg of the powder. The proteins were separated by electrophoresis on 14% polyacrylamide gel, visualized by Coomassie blue staining, and measured with a densitometer Model GS-670 22 (Bio-Rad Laboratories) for relative glutelin content to that of control plants.

The results were expressed in percentage of the glutelin content in self-fertilized seeds of untransformed, control rice plants (Tables 2 and 3).

The glutelin content was decreased to 63.2%, on average, by the transformants with the 8-tandem repeats of the glutelin A antisense gene and to 75.4% by those with the full-length glutelin A antisense gene.

Moreover, statistical analysis confirmed that the glutelin content was significantly lower in the transformants with the 8-tandem repeats of the glutelin A antisense gene than those with the full-length glutelin A antisense gene (p 0.10).

Table 2. Glutelin level in transformed plants (percentage of control) Transformants with 8-tandem repeats of glutelin antisense gene Line number Glutelin content Line number Glutelin content 1 59.9 11 66.0 2 66.9 12 76.2 3 42.3 13 48.1 4 42.6 14 83.4 66.6 15 71.7 6 77.0 16 98.2 7 39.7 17 67.8 8 40.1 18 61.0 23 55.5 46.1 93.2 61.2 Table 3. Glutelin content in transformed plants (Dercentaae of control) Transformants with full-length antisense gene of glutelin A Line number Glutelin content Line number Glutelin content 95.2 38.9 107.2 56.3 96.2 110.6 73.6 72.1 66.6 77.9 59.3 60.3 41.2 96.2 60.5 114.3 47.4 83.0 Examn1 3. Prndtniwtnn and Analvqiq nf tr~n-qn~nin' nlRntQ with both glutelin A and alutelin B antisense genes Construction of 8-tandem repeats of glutelin AB antisense gene for transformation A Smal/XbaI fragment, which contained the first intron of the castor bean catalase gene (Ohta S. et al.

(1990) Plant Cell Physiol. 31, 805-813), was inserted into the Scal/XbaI site downstream of the glutelin promoter.

Then the Xbal/SphI fragment, which contained the 8-tandem ZNN repeats of the 5'-upstream 287 bps from the full-length 24 glutelin B cDNA, was linked downstream to the above sequence, in the antisense direction. After a SphI/HindIII fragment containing the terminator of nopaline synthase was linked, the sequence was inserted into the HindIII site of plasmid vector pSBHCI x 8A, constructed in Example 2, to generate pSBHCI x 8AB (Fig. 8).

Construction of full-length glutelin AB antisense gene for transformation A SmaI/XbaI fragment, which contained the first intron of the castor bean catalase gene (Ohta S. et al.

(1990) Plant Cell Physiol. 31, 805-813), was inserted into the Scal/XbaI site downstream of the glutelin promoter.

Then, a SphI/XbaI fragment, which contained the full-length glutelin B cDNA, was linked downstream to the above sequence, in the antisense direction. After a SphI/HindIII fragment containing the terminator of nopaline synthase was linked, the sequence was inserted into the HindIII site of plasmid vector pSBHCI-FA, constructed in Example 2, to generate pSBHCI-FAB (Fig. 8).

Transformation to rice plants A variety of the rice plant, Tsukinohikari, was transformed by Agrobacterium tumefaciens LBA4404 which harbored the above plasmid pSBHCI x 8AB or pSBHCIFAB, according to the method of Hiel et al. (Plant J. 6, 271-282 (1994)). Transformed calluses were selected in the presence of hygromycin as described by Hiel et al.

Measurement of protein content in seeds Unpolished seeds from self-fertilized transformed 25 rice plants were ground and the proteins were extracted from mg of the powder. The proteins were separated by electrophoresis on 14% polyacrylamide gel, visualized by Coomassie blue staining, and the relative content of glutelin to that of control plants was measured with a densitometer Model GS-670 (Bio-Rad Laboratories).

The results were expressed in percentage of the glutelin content in the self-fertilized seeds of the untransformed, control rice plants (Table 4).

The glutelin content was reduced to 57.1%, on average, by the transformants with the 8-tandem repeats of glutelin AB antisense gene and to 69.3% by those with the full-length glutelin AB antisense gene.

Moreover, statistical analysis confirmed that the glutelin content was significantly lower in the transformants with the 8-tandem repeats of glutelin AB antisense gene than those with the full-length glutelin AB antisense gene (p<0.10).

Table 4. Glutelin content Mean Untransformed lines 100 Transformed lines with 8-tandem repeats 57.1 of glutelin AB antisense gene Transformed lines with the full-length 69.3 glutelin AB antisense gene 26 Example 4. Production and analysis of transformant with glutelin A antisense gene Construction of 2-tandem repeats and 4-tandem repeats of glutelin A antisense gene for transformation A Smal/XbaI fragment, which contained the first intron of the castor bean catalase gene (Ohta S. et al.

(1990) Plant Cell Physiol. 31, 805-813), was inserted into the Scal/XbaI site downstream of the glutelin promoter.

Then, a Xbal/SacI fragment, which contained 2-tandem repeats or 4-tandem repeats of the 5'-upstream 312 bps from the full-length glutelin A cDNA, was linked downstream to the above sequence, in the antisense direction. After a ScaI/EcoRI fragment containing the terminator of nopaline synthase was linked, the sequence was inserted into the transformation plasmid vector with the hygromycin resistance gene, thereby to generate pSBHCI x 2A and pSBHCI x 4A, respectively.

Transformation to rice plants A variety of the rice plant, Tukinohikari, was transformed by Agrobacterium tumefaciens LBA4404 which harbored the above plasmid pSBHCI x 2A or pSBHCI x 4A, according to the method of Hiel et al. (Plant J. 6, 271-282 (1994)). Transformed calluses were selected in the presence of hygromycin as described by Hiel et al. (ibid).

Measurement of protein content in seeds Unpolished seeds of self-fertilized transgenic rice plants were ground and the proteins were extracted from mg of the powder. The proteins were separated by 27 electrophoresis on 14% polyacrylamide gel visualized by Coomassie blue staining, and measured with a densitometer Model GS-670 (Bio-Rad) for the relative content of glutelin to that of control plants. The result was expressed in percentage of the glutelin level in the self-fertilized seeds of the untransformed, control rice plants (Tables and 6).

The glutelin content was decreased to 71.7%, on average, by the transformants with the 2-tandem repeats of the glutelin A antisense gene and to 71.5% by those with the 4-tandem repeats of the glutelin A gene.

Table 5. Glutelin content in transgenic plants (percentage of control) Transformants with 2-tandem repeats of the glutelin A antisense gene Line number Glutelin content 1 66.5 2 66.2 3 67.5 4 93.8 64.2 6 60.6 7 75.0 8 79.5 Mean 71.7 28 Table 6 Glutelin content in transaenic plants Nd (Dercentaae of control) Transformants with 4-tandem repeats of the glutelin A antisense gene Line number Glutelin content 1 54.7 2 89.0 3 93.9 4 64.1 68.0 6 66.7 7 67.0 8 73.1 9 67.0 Mean 71.5 EFFECT OF THE INVENTION The antisense nucleotide sequence in the present invention represents a single copy of tandem repeats of the structural gene of interest or a fragment thereof which are successively linked in the antisense direction. The antisense RNA transcribed from the antisense nucleotide sequence consists of plural repeats of the RNA sequence each being complementary to the corresponding part of the mRNA of the target protein. Therefore, the antisense RNA has a higher ability to hybridize with the mRNA and to suppress N, the in vivo expression of the protein. Thus, the antisense 29 RNA of the invention containing such tandem repeats is superior to an antisense RNA without any such repeats in suppressing the synthesis of target proteins.

The description has been made mainly on the basis of suppression to the synthesis of plant proteins. Needless to say, however, the antisense sequence of the present invention is useful for suppressing the synthesis of animal proteins such as specific milk proteins or specific proteins for the purpose of treating immunological or pathogenic diseases.

Soo: Throughout this specification and the claims, the words "comprise", "comprises" and "comprising" are used in a non-exclusive sense, except where the context requires otherwise.

*o• *oB 30 SEQUENCE LISTING INFORMATION FOR SEQ ID NO: 1: SEQUENCE CHARACTERISTICS: LENGTH: 1644 base pairs TYPE: nucleic acid STRANDEDNESS: double TOPOLOGY: linear (ii) MOLECULAR TYPE: cDNA to mRNA (vi) ORIGINAL SOURCE:

ORGANISM:

(ix) FEATURE: Glutelin A cDNA (xi) SEQUENCE DESCRIPTION: SEQ ID AAGTACGACG AAAATTCATT AGTACTACAA CAAC

NO:

ATG

Met 1: GCA TCC ATA AAT CGC CCC Ala Ser Ile Asn Arg Pro ATA GTT TTC Ile Val Phe TTC ACA GTT TGC TTG TTC CTC TTG TGC Phe Thr Val Cys Leu Phe Leu Leu Cys

AAT

Asn GGC TCT CTA Gly Ser Leu GCC CAG Ala Gin CAG CTA TTA GGC Gln Leu Leu Gly

CAG

Gin 30 AGC ACT AGT CAA Ser Thr Ser Gln

TGG

Trp CAG AGT TCT CGT Gin Ser Ser Arg 103 151 199 247

CGT

Arg GGA AGT CCA AGA Gly Ser Pro Arg

GAA

Glu 45 TGC AGG TTC GAT Cys Arg Phe Asp

AGG

Arg 50

ACA

Thr TTG CAA GCA TTT GAG Leu Gln Ala Phe Glu CCA ATT CGG AGT Pro Ile Arg Ser GTG AGG Val Arg TCT CAA GCT Ser Gin Ala

GGC

Gly 65 ACT GAG TTC Thr Glu Phe TTC GAT Phe Asp GTC TCT AAT Val Ser Asn GTT ATT GAA Val Ile Glu

GAG

Glu CAA TTT CAA TGT Gin Phe Gin Cys

ACC

Thr 80 GGA GTA TCT GTT Gly.Val Ser Val GTC CGT CGA Val Arg Arg AAT GGT GCA Asn Gly Ala CCT AGA GGC CTT Pro Arg Gly Leu

CTA

Leu 95 CTA CCC CAT TAC Leu Pro His Tyr

ACT

Thr 100 295 343 391 439 TCT CTA Ser Leu 105 GTA TAT ATC ATC Val Tyr Ile Ile

CAA

Gin 110 GGG AGA GGT ATA Gly Arg Gly Ile

ACA

Thr 115 GGG CCA ACT TTC Gly Pro Thr Phe

CCA

Pro 12.0 GGC TGT CCT GAG Gly Cys Pro Glu

TCC

Ser 125 TAC CAA CAA CAG Tyr Gin Gin Gin

TTC

Phe 130 CAA CAA TCA GGC Gin Gin Ser Gly

CAA

Gin 135 GCC CAA TTG ACC GAA AGT CAA AGC CAA AGT CAA AAG TTC AAG Ala Gin Leu Thr Glu Ser Gin Ser Gin Ser Gln Lys Phe Lys 140 145 GAT GAA Asp Glu 150 487 31 CAT CAA AAG His Gin Lys GGT GGT GTA Ala Gly Vai 170 GAG CGT TTC AGA His A-rg ?he Arg

CAA

Gin 160 GGA GAT GTA ATT Giy Asp Val Ile GCA TTG GCT Ala Leu Pro 165 CCA GTT GTT Pro Val Val 535 583 GCT CAT TGG TGC Ala His Trp Gys

TAC

Tyr 175 AAT GAT GGT GAA Asn Asp Giy-Giu

GTG

Val 180 GCC ATA Ala Ile 185 TAT GTC ACT GAT Tyr Val Thr Asp

CTC

Leu 190 AAG AAC GGT GCT Asn Asn Gly Ala

AAT

As n 195 CAA CTT GAC CCT Gin Leu Asp Pro

AGG

Ar; 200 CAA AGG CAT TTC Gin AZ; Asp ?he

TTG

Leu 205 TTA GCT GCA AAT Leu Ala Gly Asn

AAG

Lys 210 AGA AAC GOT CAA Arg Asn Pro Gin

GCA

Al a 215 631 679 727 TAG AGG CGT GAG Tyr Arg A-rg Giu GTT GAG Val Giu 220 GAG CGG TCA Giu Arg Ser

CAG

Gin 225 AAC ATA TTT AGT Asn Ile ?he Ser GGC TTT Giy Phe 230 AGC ACT GAA Ser Thr Giu AGG GAG CTC A-r; Gin Leu 250 GAA GAC GGG Giu His Gly 265

CTA

Leu 235 CTT AGC GAG GCT Leu Ser Giu Ala

CTT

Leu 240 GGC GTA AGC GGC Gly Val. Ser Giy CAA GTG GCA Gin Val Ala 245 GTC CGT GTC Val Ar; Val CAA TGT CAA AAT Gin Gys Gin Asn

CAC

Asp 255 CAA AGA GGA GAA Gin Arg Gly Giu

ATT

Ile 260 775 823 871 CTC AGT TTG Leu. Ser Leu

CTG

Leu 270 CAG CCA TAT GCA Gin Pro Tyr Ala

TCA

Ser 275 TTG CAG GAG CAG Leu Gin Giu Gin7

GAA

Giu 280 CAA GCA CAA GTG Gin Giy Gin Val

CAA

Gin 285 TCA AGA GAG CGT Ser Ar; Giu Ar;

TAT

Tyr 290 CAA GAA GGA CAA Gin Giu Gly Gin

TAT

Tyr 295 919 967 CAG CAA Gin Gin AGT CAA TAT Ser Gin Tyr 300 GGA AGT GGC TGC Giy Ser Giy Cys

TCT

Ser 305 AAC GGT TTG CAT Asn Gly Leu Asp GAG ACC Giu Thr 310 TTT TGC ACC Phe Cys Thr CAT ACA TAC Asp Thr Tyr 330

CTG

Leu 315 AGG GTA AGG CAA Arg Val Arg Gin

AAG

Asn 320 ATG GAT AAT CCT Ile Asp Asn Pro AAC CGT GCT Asn Arg Ala 325 AAC ACC CAG Asn Thr Gin 1015 1063 AAT CCA AGA GCT Asn Pro A-rg Ala

GGA

Giy 335 AGG GTT ACA AAT Arg Vai Thr Asn

CTC

Leu 340 AAT TTC Asn ?he 345 CCC ATT CTC AGT Pro Ile Leu Ser

CTT

Leu 350 GTA CAG ATG AGT Val Gin Met Ser

GCA

Al a 355 GTC AAA GTA AAT Vai Lys Val Asn 1111 1159

CTA

Leu 360 TAG GAG AAT GGA Tyr Gin Asn Aia

CTG

Leu 365 GTT TCA CCA TTT Leu Ser Pro Phe

TGG

Trp, 370

AAG-ATG

Asri Ile AAG GGT GAG Asn Ala His 375 GTG TAT ATT ACT CAA GGC GGT GGG CGG GTT CAA GTT GTC AAG 1207 -32 Ser Vai Val Tyr Ile 380 Thr Gin Giy Azg Ala 385 Arg Val Gin Val Val Asn 390 AAG AAT GGA Asn Asn Gly CTT ATT ATA Leu Ile Ile 410

AAG

Lys 395 AGA GTG TTG AAG Thr Val ?he Asn

GGG

Gly 400 GAG GTT GG CGC Giu Leu Arg Arq GGA GAG GTG Gly Gin Leu 405 GAA AGA GAA Gin Arg Giu 1255 1303 GGA CAA CAC TAC Pro Gin His Tyr

GCA

Al1 a 415 GTT GTA AAG AAG Val Val Lys Lys

GGA

Ala 420

GGA

Gly

GAG

His 440

TGT

Gys 425 GCT TAG ATT GGA Ala Tyr Ile Ala

TTG

Phe 430 AAG AGG AAT GGT Lys Thr Asn Pro

AAG

As n 435 TGT ATG GTA AGG Ser Met Val Ser ATT GGA GGA AAG Ile Ala Giy Lys

AGT

Ser 445 TGG ATC TTG CGT Ser Ile Phe Arg

GGT

Ala 450 GTG GGA AAT GAT Leu Pro Asn. Asp

GTT

Val1 455 1351 1399 1447 1495 GTA GGA AAT GGA Leu Ala Asn Ala GAT AAT AGA GGA His Asn Arg Gly 475

TAT

Tyr 460 CG ATG TGA AGA Arg Ile Ser Arg

GAA

Giu 465

TTG

Phe GAG GGT GAG AGG Giu. Ala Gin Arg GTG AAG Leu Lys 470 GAT GAG TTG GGT Asp Glu Phe Giy

GGA

Al a 480

ACT

Thr CGA ATG GAA TAG AAG Pro Ile Gin Tyr Lys 485 AGG TAG GAA Ser Tyr Gin 490 GAG GTT TAT AAT Asp Val Tyr Asn

GG

Al a 495 GGA GAA TGG TGT Ala Glu Ser Ser TAG GTGGGTTGG GG 1546 Stop 500 ATAAAGAATA AGTAAATAAA TAAATTGGAA GGAATTGTTT TGCTGGTATG TAGTGTGGAG 1606 TCTTTGGACT AATGATGATA AAGCCTCTGT TTATGGTT 1644 INFORMATION~ FOR SEQ ID NIO: 2: SEQUENGE GH.ARATERISTIGS: LENGTH: 1634 base pairs TYPE: nucleic acid STRANDEDNESS: double TOPOLOGY: linear (ii) MOLEGULAR TYPE: cDNA to mRNA ORIGINAL SOURGE:

ORGANISM:

(ix) FEATURE: Glutelin B cDNA (xi) SEQUJENGE DESGRIPTION: SEQ ID GTAGAAATAG GT ATG GGG AGC TGG GTT TTG Met Ala Ser Ser Val ?he

NO:

TGT

Ser 2

CGG

A.rg TTT TGT Phe Ser ATA TAG TTT Ile Tyr Phe TGT GTT GTT GTA TTA TGG CAT GGT TGT ATG GCC GAG GTA TTT AAT GGG C.ys Val Leu Leu Leu Gys His Giy Ser Met Ala Gin Leu Phe Asn Pro 20 33

AGC

Ser ACA AAC CCA TGG Thr Asri Pro Trp CAT AGT CCT CGG His Ser Pro Arg 35 CAA GCA TTT GAA Gin Ala ?he Giu CAA GGA Gin Giy 40 AGT TTT AGG GAG Ser Phe Arg Giu

TGT

Cys 147 195 AGA TTT GAT AGA Axg ?he Asp Arg

CTA

Leu

CCA

Pro 55 CTT CGG AAA GTG Leu Arg Lys Val AGG TCA Arg Ser GAA GCT GGG Giu Al1a Gly TGC ACG GGT Gys Thzr Gly

GTG

Val ACT GAG TAC TTC Thr Giu Tyr Phe

GAT

Asp 70 GAG AAG AAT GAA Giu Lys Asn Giu *TTA TTC CAG Leu Phe Gin CAA GGG CTT Gin Giy Leu ACT TTT GTG ATC Thr Phe Val. Ile

CGA

Arg 85 CGT GTC, ATT GAG Arg Val Ile Gin

CT

Pro TTG GTA Leu Val CCT GGA TAC Pro Arg Tyr

AGA

Thr

GGT

Giy 115

CAA

Gin

AAT

Asn 100 ATT CCT GGC GTG Ile Pro Gly Val 243 291 339 387 435

GTC

Val 105 TAC ATC ATC CAA Tyr Ile Ile Gin

GGG

Giy 110

CAG

Gin AGA GGT TCT Arg Giy Ser CAA CAA TTC Gin Gin Phe

ATG

Met

CAA

Gin 130 TTA ACC TTC, CCC Leu Thr Phe -Pro

GGT

Giy 120

GGC

Gly TGC CCT GCG Cys Pro Ala CAA AGT GAG Gin Ser Gin

TAG

Tyr 125

CAA

Gin TTT TGA TCT Phe Ser Ser

CAA

Gin 135 AAG TTT AGA Lys ?he Arg ATT GTT GGT Ile Vai Ala 160 GAT GAG GAG CAA Asp Giu His Gin 145 CTG GGA GGT GGT Leu Pro Ala Giy AAG ATT Lys Ile 150 CAT CAA TTT AGG His Gin Phe Arg GAA GGA GAG Gin Gly Asp 155 AAT GAT GGT Asn Asp Gly 483 531

GTT

Val 165 GGA CAT TGG TTG Ala His Trp Phe

TAG

Tyr 170 GAT GG Asp Arg .175 CAT ATT GTT GCG His Ile Vai Ala

GTA

Val1 180 TAT GTT TAT GAC Tyr Val Tyr Asp GTA AAG AAG AAG Val Asn Asn Asn 185 TTA GGG GGG AAG Leu Ala Gly Asn

GGG

Al a

AAG

As n 205

AAT

As n 190 GAG GTT GAA GGT AGG Gin Leu Giu Pro Arg 195 GAA AAG GAG TTG Gin Lys Giu ?he

GTA

Leu 200 579 627 675 AAT GGG GGT CAA Asn Arg Ala Gin

GAA

Gin 210 CAA GAA GTA TAT Gin Gin Vai Tyr

GGT

Giy 215 AGC TGA ATT GAG Ser Ser Ile Giu CAA GAG Gin His 220

TGT

Ser GGG GAA AAC Gly Gin Asn 225 ATA TTG AGG GGA Ile Phe Ser Gly

TTT

Phe 230 GGT GTT GAG ATG Giy Val Giu-Met GTA AGT GAG Leu Ser Giu 235 AGG CGA AAT Ser Pro Asn 723 771 GCT TTA GGG Ala Leu Gly 240 ATG AAG GCA GTA Ile A~sn Ala Val

GCA

Al a 245 GCA AAG AGG CTA Ala Lys Arg Leu

GAG

Gin 250 AGA GGA GAG ATC ATA CAT GTG AAG AAT GGG OTT CAA TTG TTG 819 34 Asp Gin 255 Azg Gly Giu Ile Ile 260 His Val. Lys Asn Gly 265 Leu Gin Leu Leu Lys 270 CCG ACT TTG ACA Pro Thr Leu Thr

CAA

Gin 275 CAG CANA GAA CAA Gin Gin Giu Gin

GCA

A-la 280 CA?. GCA CAA GAT Gin Ala Gin Asp

CAA

Gin 285 867 915 TAT CAA CAA GTT Tyr Gin Gin Vai

CA

Gin 290 TAC AGT GAA. CGA Tyr Ser Giu Arg CAG CAA Gin Gin 295 ACA TCT TCT Thr Ser Ser CGA TGG Arg Trp 300 AAC GGA TTG Asn Gly Leu GAA AAT CCT Giu Asn Pro 320

GAG

Giu 305 GAG AAC TTT TGC Giu Asn Phe Cys

ACG

Thr 310 ATC AAG GTG AGA Ile Lys Vai Arg GTA AAC ATT Val Asn Ile 315 GGA AGG ATA Giy Arg Ile 963 1011.

AGT CGT GCT GAT TCA Ser Xrg A1 ,a Asp Ser 325 TAC AAC CCA CGT Tyr Asn Pro Arg

GCC

A.a 330 ACA AGT Thr Ser 335 GTC AAT AGT CAG Val Asn Ser Gin

AAG

Lys 340.

TTC CCC ATC CTT Phe Pro Ile Leu

AAC

Asn 345 CTC ATC CAA ATG Leu Ile Gin Met

AGC

Ser 350 GCT ACC AGA GTA Ala Thr Arg Vai

AAC

As n 355 CTA TAC CAG AAT Leu Tyr Gin Asn

GCT

Al a 360 ATT CTC TCG CCG Ile Leu Ser Pro

TTC

Phe 365 1059 1107 1155 TGG AAC GTC AAT Trp Asn Val. Asn

GCT

Al a 370 CAT AGT TTG GTC His Ser Leu Val.

TAT

Tyr 375 ATG ATT CAA GGG Met Ile Gin Giy CGA TCT Arg Ser 380 CGA GTT CAA Xrg Vai Gin CTT CGC CCA Leu Arg Pro 400

GTC

Val1 385 GTT AGT AAC TTT Val. Ser Asn Phe

GGA

Gly 390 AAG ACT GTG TTT Lys Thr Vai Phe GAT GGT GTC Asp Gly Vai 395 GCT GTC TTG Ala Val Leu 1203 1251 GGA CAA TTA TTG Giy Gin Leu Leu

ATC

Ile 405 ATT CCG CAA CAT Ile Pro Gin His

TAT

Tyr 410 AAG AAA Lys Lys 415 GCA GAG CGT GAA Ala Giu Axg Giu

GGA

Giy 420 TGC CAA TAT ATC Cys Gin Tyr Ile GCA ATC AAG ACA Ala Ile Lys Thr 425 AAC TCA GTA TTC As n Ser Vai Phe

AAC

As n

CGT

Arg 445

GCT

Ala 430 AAC ACC TTC GTC Asn Thr.Phe Val

AGC

Ser 435 CAC CTT GCA GGG His Leu Ala Giy

AAA

Lys 440 1299 1347 1395 GCC TTG CCA GTT Ala Leu Pro Val

GAT

Asp 450 GTA GTC GCT AAT Vai Val Ala Asn

GCG

Ala 455 TAT CGC ATC TCA Tyr Arg Ile Ser AGG GAG Ar g Giu 460 CAA GCC CGA Gin Ala Arg

AGC

Ser 465 CTC AAG AAC AAC Leu Lys Asn Asn

AGG

Arg 470 GGA GAA GAG CAC Gly Giu Giu His GGT GCC TTC Gly Ala Phe 475 1443 ACT CCT AGA TTT CAA CAA CAA TAC TAC CCA GGA TTA TCG AAT GAG TCC 7-hr Pro Arg Phe Gin Gin Gin Tyr Tyr Pro Gly Leu Ser Asn Glu Ser 1491 480 485 490 GAA AGC GAG ACC TCA GAG TAA TGTAATGTAA TTGAGAACTA GTATCGGCGT AGAG 1546 Glu Ser Glu Thr Ser Glu Stop 495 500 TAAAATAAAA CACCACAAGT ATGACACTTG GTGGTGATTC TGTTCGATAT CAGTACTAAA 1606 TAAAGGTTAC AAACTTCTTA ATTTTCCT 1634 INFORMATION FOR SEQ ID NO: 3: SEQUENCE CHARACTERISTICS: LENGTH: 30 base pairs TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULAR TYPE: Other nucleic acids, synthetic DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3: AGTGGGCTGC AGGAATTCGA TATCAAGCTT INFORMATION FOR SEQ ID NO: 4: SEQUENCE CHARACTERISTICS: LENGTH: 20 base pairs TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULAR TYPE: Other nucleic acids, synthetic DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4: AGTACATAGC AGCAAAACAT INFORMATION FOR SEQ ID NO: SEQUENCE CHARACTERISTICS: LENGTH: 25 base pairs TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULAR TYPE: Other nucleic acids, synthetic DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: TACATAGCTT TAACTGATAA TCTGA INFORMATION FOR SEQ ID NO: 6: SEQUENCE CHARACTERISTICS: LENGTH: 20 base pairs TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULAR TYPE: Other nucleic acids, synthetic DNA (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6: 36 AGTACATAGC AGCAAAACAT 37

Claims (13)

1. An antisense nucleotide sequence comprising two or more successive repeats of the structural gene of interest or a fragment thereof in the antisense direction.

2. An antisense nucleotide sequence as claimed in Claim 1, which comprises two or more successive repeats of the sequence of a 5' region of the desired gene of interest.

3. An antisense nucleotide sequence as claimed in Claim 2, wherein the sequence of 5' region comprises at least nucleotides.

4. An antisense nucleotide sequence as claimed in Claim 2, wherein the sequence of 5' region comprises at least 300 nucleotides.

5. An antisense nucleotide sequence as claimed in any of Claims 1 to 4, which comprises at least 4 repetitions of the Sstructural gene of interest or a fragment thereof.

6. An antisense nucleotide sequence as claimed in any of Claims 1 to 4, which comprises at least 8 repetitions of the structural gene of interest or a fragment thereof.

7. An antisense nucleotide sequence as claimed in any of Claims 1 to 6, which comprises different sets of two or more successive repeats of the structural gene of interest or a fragment thereof in the antisense direction.

8. An antisense nucleotide sequence as claimed in any of Claims 1 to 7, wherein said gene of interest is a gene coding for a storage protein of a plant seed.

9. An antisens nucleotide sequence as claimed in Claim S 8, wherein the storage protein is glutelin A or glutelin B. 38 An expression vector comprising an antisense nucleotide sequence of any of Claims 1-9.

11. A transgenic host which has been transfromed by an expression vector of Claim

12. A transgenic host of Claim 11, which is a plant.

13. A transgenic host of Claim 11 or 12, which is a rice plant.

14. A method for suppressing the in vivo expression of the protein of interest encoded by a structural gene comprising introducing an antisense nucleotide sequence of any of Claims 1-9 against said structural gene into the genomic gene of a target cell. 39